Ajax-Loading

Johnson & Johnson - Total Debt To Ebitda

Johnson & Johnson's Fiscal Year is From January To December.

The item "Total-Debt-To-Ebitda" stands at 1.16 as of 09/30/2025, the lowest value since 12/31/2022.

As of the end of Johnson & Johnson's third quarter, the item "Total Debt To Ebitda" stands at 1.16. This represents a decrease of -18.70 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -16.84 percent compared to the value the year prior.
The 1 year change in percent is -16.84.
The 3 year change in percent is 8.39.

The Serie's long term average value is 1.42. It's latest available value, on 09/30/2025, is 18.41 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +8.39%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -50.63%.

Total Debt To Ebitda for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Debt To Ebitda905,699,262,464.00
LogoAbbVie Inc - Total Debt To Ebitda399,570,305,024.00
LogoRoche Holding AG - Total Debt To Ebitda317,433,206,677.55
LogoAstraZeneca PLC - Total Debt To Ebitda280,205,508,085.11
LogoNovartis AG - Total Debt To Ebitda255,096,620,580.91